Compare Becton Dickinson and Co (BDX) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs 3M Company — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while 3M Company trades at $156.2 (market cap $81.67B). The key difference: 3M Company is the larger of the two by market cap, and Becton Dickinson and Co pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| BDX | MMM | |
|---|---|---|
Market Cap | $41.51B | $81.67B |
Sector | Health | Industrials |
52-Week High | $185.39 | $174.61 |
52-Week Low | $135.49 | $141.10 |
Enterprise Value | $57.97B | $90.07B |
Dividend Yield | 2.79% | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
3M (MMM) trades at $157.70, showing minimal daily movement with a 0.11% gain. The stock faces technical headwinds with bearish moving averages but maintains strong profitability metrics including a 72.14% ROE and consistent earnings beats. Recent developments include new product launches and strategic partnerships, though the company navigates consumer segment weakness and mixed analyst sentiment.
The outlook remains balanced with solid fundamentals supporting long-term value, but near-term risks include competitive pressures and macroeconomic sensitivity. Analyst consensus suggests cautious optimism with a $143 price target, while technical indicators signal potential consolidation around current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
